Nano-X Imaging (NASDAQ:NNOX – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at D. Boral Capital in a research report issued on Monday,Benzinga reports. They presently have a $15.00 target price on the stock. D. Boral Capital’s price target would indicate a potential upside of 198.63% from the stock’s previous close.
Separately, Cantor Fitzgerald raised their price objective on shares of Nano-X Imaging from $11.00 to $12.00 and gave the company an “overweight” rating in a research report on Friday, December 6th.
View Our Latest Report on NNOX
Nano-X Imaging Price Performance
Nano-X Imaging (NASDAQ:NNOX – Get Free Report) last posted its quarterly earnings data on Monday, March 31st. The company reported ($0.23) EPS for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.08). Nano-X Imaging had a negative return on equity of 27.63% and a negative net margin of 465.38%. As a group, analysts predict that Nano-X Imaging will post -0.92 EPS for the current fiscal year.
Institutional Trading of Nano-X Imaging
Institutional investors and hedge funds have recently bought and sold shares of the stock. US Bancorp DE lifted its stake in shares of Nano-X Imaging by 388.7% in the 4th quarter. US Bancorp DE now owns 3,470 shares of the company’s stock valued at $25,000 after purchasing an additional 2,760 shares during the last quarter. Quadrant Capital Group LLC raised its position in shares of Nano-X Imaging by 464.9% in the fourth quarter. Quadrant Capital Group LLC now owns 7,016 shares of the company’s stock valued at $51,000 after purchasing an additional 5,774 shares during the period. Quantum Private Wealth LLC acquired a new stake in shares of Nano-X Imaging in the fourth quarter worth $72,000. Signaturefd LLC grew its position in shares of Nano-X Imaging by 164.6% in the fourth quarter. Signaturefd LLC now owns 10,391 shares of the company’s stock valued at $75,000 after purchasing an additional 6,464 shares during the last quarter. Finally, PharVision Advisers LLC bought a new position in Nano-X Imaging in the 4th quarter worth approximately $80,000. Institutional investors and hedge funds own 21.49% of the company’s stock.
About Nano-X Imaging
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.
Read More
- Five stocks we like better than Nano-X Imaging
- Growth Stocks: What They Are, What They Are Not
- 3 Stocks Near 52-Week Lows With Strong Rebound Potential
- What is the Shanghai Stock Exchange Composite Index?
- Casey’s General Stores Insider Buys Shares of This Must-Own Stock
- A Deeper Look at Bid-Ask Spreads
- U.S. Steel and Nippon Merger: Should Investors Bet on It?
Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.